Intercellular communication in atherosclerosis

Physiology

Volumn 24, Issue 1, 2009, Pages 36-44

  Burnier, Laurent ^a,b   Fontana, Pierre ^a   Angelillo Scherrer, Anne ^b   Kwak, Brenda R ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAP JUNCTION PROTEIN;

ANIMAL; ATHEROSCLEROSIS; BLOOD VESSEL; CELL COMMUNICATION; CELL JUNCTION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; ATHEROSCLEROSIS; BLOOD VESSELS; CELL COMMUNICATION; CONNEXINS; ENDOTHELIUM, VASCULAR; GAP JUNCTIONS; HUMANS;

EID: 59849098242     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiol.00036.2008     Document Type: Review

References (148)

1. Alvarez Garcia B, Ruiz C, Chacon P, Sabin JA, Matas M. High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg 38: 1018-1024, 2003.
2. Alves LA, Coutinho-Silva R, Persechini PM, Spray DC, Savino W, Campos de Carvalho AC. Are there functional gap junctions or junctional hemichannels in macrophages? Blood 88: 328-334, 1996.
3. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 11: 1223-1230, 1991.
4. Angelillo-Scherrer A, Roth I, Sugemele R, Goodenough D, Chanson M, Kwak BR. Abstract 277: prominent role for the Gap junction protein connexin37 in hemostasis and thrombosis. Circulation 114: II-27, 2006.
5. Bastiaanse EM, Jongsma HJ, van der Laarse A, Takens-Kwak BR. Heptanol-induced decrease in cardiac gap junctional conductance is mediated by a decrease in the fluidity of membranous cholesterol-rich domains. J Membr Biol 136: 135-145, 1993.
6. Bermudez-Fajardo A, Yliharsila M, Evans WH, Newby AC, Oviedo-Orta E. CD4+ T lymphocyte subsets express connexin 43 and establish gap junction channel communication with macrophages in vitro. J Leukoc Biol 82: 608-612, 2007.
7. Beyer EC, Steinberg TH. Evidence that the gap junction protein connexin-43 is the ATP-induced pore of mouse macrophages. J Biol Chem 266: 7971-7974, 1991.
8. Blackburn JP, Peters NS, Yeh HI, Rothery S, Green CR, Severs NJ. Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 15: 1219-1228, 1995.
9. Boerma M, Forsberg L, Van Zeijl L, Morgenstern R, De Faire U, Lemne C, Erlinge D, et al. A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med 246: 211-218, 1999.
10. Bolon ML, Ouellette Y, Li F, Tyml K. Abrupt reoxygenation following hypoxia reduces electrical coupling between endothelial cells of wild-type but not connexin40 null mice in oxidant- and PKA-dependent manner. FASEB J 19: 1725-1727, 2005.
11. Branes MC, Contreras JE, Saez JC. Activation of human polymorphonuclear cells induces formation of functional gap junctions and expression of connexins. Med Sci Monit 8: BR313-BR323, 2002.
12. Bruzzone R, Haefliger JA, Gimlich RL, Paul DL. Connexin40, a component of gap junctions in vascular endothelium, is restricted in its ability to interact with other connexins. Mol Biol Cell 4: 7-20, 1993.
13. Buchner K, Henn V, Grafe M, de Boer OJ, Becker AE, Kroczek RA. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis. J Pathol 201: 288-295, 2003.
14. Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 101: 2661-2666, 2003.
15. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 336: 1276-1282, 1997.
16. Chadjichristos CE, Matter CM, Roth I, Sutter E, Pelli G, Luscher TF, Chanson M, et al. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation 113: 2835-2843, 2006.
17. Chadjichristos CE, Morel S, Derouette JP, Sutter E, Roth I, Brisset AC, Bochaton-Piallat ML, et al. Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circ Res 102: 653-660, 2008.
18. Chadjichristos CE, Roth I, Hoepfl B, vanVeen TAB, Deutsch U, vanKempen MJA, de Wit C, et al. Increased Development of Atherosclerosis in Mice with Endothelial-Specific Deletion of Connexin40. Presented at the American Heart Association annual meeting, Dallas, TX. 2005.
19. Chanson M, Derouette JP, Roth I, Foglia B, Scerri I, Dudez T, Kwak BR. Gap junctional communication in tissue inflammation and repair. Biochim Biophys Acta 1711: 197-207, 2005.
20. Christ GJ, Spray DC, el-Sabban M, Moore LK, Brink PR. Gap junctions in vascular tissues. Evaluating the role of intercellular communication in the modulation of vasomotor tone. Circ Res 79: 631-646, 1996.
21. Collings A, Islam MS, Juonala M, Rontu R, Kahonen M, Hutri-Kahonen N, Laitinen T, et al. Associations between connexin37 gene polymorphism and markers of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns study. Atherosclerosis 195: 379-384, 2007.
22. Cowan DB, Lye SJ, Langille BL. Regulation of vascular connexin43 gene expression by mechanical loads. Circ Res 82: 786-793, 1998.
23. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251: 788-791, 1991.
24. Davies PF, Shi C, Depaola N, Helmke BP, Polacek DC. Hemodynamics and the focal origin of atherosclerosis: a spatial approach to endothelial structure, gene expression, and function. Ann NY Acad Sci 947: 7-16, 2001.
25. De Maio A, Vega VL, Contreras JE. Gap junctions, homeostasis, injury. J Cell Physiol 191: 269-282, 2002.
26. de Wit C, Hoepfl B, Wolfle SE. Endothelial mediators and communication through vascular gap junctions. Biol Chem 387: 3-9, 2006.
27. de Wit C, Roos F, Bolz SS, Kirchhoff S, Kruger O, Willecke K, Pohl U. Impaired conduction of vasodilation along arterioles in connexin40-deficient mice. Circ Res 86: 649-655, 2000.
28. de Wit C, Roos F, Bolz SS, Pohl U. Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion. Physiol Genomics 13: 169-177, 2003.
29. DePaola N, Davies PF, Pritchard WF Jr, Florez L, Harbeck N, Polacek DC. Spatial and temporal regulation of gap junction connexin43 in vascular endothelial cells exposed to controlled disturbed flows in vitro. Proc Natl Acad Sci USA 96: 3154-3159, 1999.
30. Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO, Wagner DD. The combined role of P-and E-selectins in atherosclerosis. J Clin Invest 102: 145-152, 1998.
31. Eugenin EA, Branes MC, Berman JW, Saez JC. TNF-alpha plus IFN-gamma induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses. J Immunol 170: 1320-1328, 2003.
32. Eugenin EA, Eckardt D, Theis M, Willecke K, Bennett MV, Saez JC. Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon-gamma and tumor necrosis factor-alpha. Proc Natl Acad Sci USA 98: 4190-4195, 2001.
33. Figueroa XF, Isakson BE, Duling BR. Connexins: gaps in our knowledge of vascular function. Physiology (Bethesda) 19: 277-284, 2004.
34. Figueroa XF, Isakson BE, Duling BR. Vascular gap junctions in hypertension. Hypertension 48: 804-811, 2006.
35. Firouzi M, Kok B, Spiering W, Busjahn A, Bezzina CR, Ruijter JM, Koeleman BP, et al. Polymorphisms in human connexin40 gene promoter are associated with increased risk of hypertension in men. J Hypertens 24: 325-330, 2006.
36. Frenette PS, Denis CV, Weiss L, Jurk K, Subbarao S, Kehrel B, Hartwig JH, et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 191: 1413-1422, 2000.
37. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145: 33-43, 1999.
38. Gabriels JE, Paul DL. Connexin43 is highly localized to sites of disturbed flow in rat aortic endothelium but connexin37 and connexin40 are more uniformly distributed. Circ Res 83: 636-643, 1998.
39. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90: 251-262, 2002.
40. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503, 1994.
41. Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 96: 2311-2315, 1999.
42. Goldberg IJ. Why does diabetes increase atherosclerosis? I don't know! J Clin Invest 114: 613-615, 2004.
43. Gros D, Jarry-Guichard T, Ten Velde I, de Maziere A, van Kempen MJ, Davoust J, Briand JP, et al. Restricted distribution of connexin40, a gap junctional protein, in mammalian heart. Circ Res 74: 839-851, 1994.
44. Haefliger JA, Polikar R, Schnyder G, Burdet M, Sutter E, Pexieder T, Nicod P, et al. Connexin37 in normal and pathological development of mouse heart and great arteries. Dev Dyn 218: 331-344, 2000.
45. Han Y, Xi S, Zhang X, Yan C, Yang Y, Kang J. Association of connexin 37 gene polymorphisms with risk of coronary artery disease in northern Han Chinese. Cardiology 110: 260-265, 2008.
46. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6: 508-519, 2006.
47. Hao H, Ropraz P, Verin V, Camenzind E, Geinoz A, Pepper MS, Gabbiani G, et al. Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler Thromb Vasc Biol 22: 1093-1099, 2002.
48. Hill CE, Phillips JK, Sandow SL. Heterogeneous control of blood flow amongst different vascular beds. Med Res Rev 21: 1-60, 2001.
49. Hill CE, Rummery N, Hickey H, Sandow SL. Heterogeneity in the distribution of vascular gap junctions and connexins: implications for function. Clin Exp Pharmacol Physiol 29: 620-625, 2002.
50. Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y, Tajika T, et al. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 42: 1429-1437, 2003.
51. Hong T, Hill CE. Restricted expression of the gap junctional protein connexin 43 in the arterial system of the rat. J Anat 192: 583-593, 1998.
52. Horan PG, Allen AR, Patterson CC, Spence MS, McGlinchey PG, McKeown PP. The connexin 37 gene polymorphism and coronary artery disease in Ireland. Heart 92: 395-396, 2006.
53. Hou CJ, Tsai CH, Su CH, Wu YJ, Chen SJ, Chiu JJ, Shiao MS, et al. Diabetes reduces aortic endothelial gap junctions in ApoE-deficient mice: simvastatin exacerbates the reduction. J Histochem Cytochem 56: 745-752, 2008.
54. Hu J, Cotgreave IA. Differential regulation of gap junctions by proinflammatory mediators in vitro. J Clin Invest 99: 2312-2316, 1997.
55. Hu VW, Xie HQ. Interleukin-1 alpha suppresses gap junction-mediated intercellular communication in human endothelial cells. Exp Cell Res 213: 218-223, 1994.
56. Hulser DF, Peters JH. Intercellular communication in phytohemagglutinin- induced lymphocyte agglutinates. Eur J Immunol 1: 494-495, 1971.
57. Ikonomidis I, Stamatelopoulos K, Lekakis J, Vamvakou GD, Kremastinos DT. Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 199: 3-11, 2008.
58. Inai T, Mancuso MR, McDonald DM, Kobayashi J, Nakamura K, Shibata Y. Shear stress-induced upregulation of connexin 43 expression in endothelial cells on upstream surfaces of rat cardiac valves. Histochem Cell Biol 122: 477-483, 2004.
59. Isakson BE, Kronke G, Kadl A, Leitinger N, Duling BR. Oxidized phospholipids alter vascular connexin expression, phosphorylation, and heterocellular communication. Arterioscler Thromb Vasc Biol 26: 2216-2221, 2006.
60. Jara PI, Boric MP, Saez JC. Leukocytes express connexin 43 after activation with lipopolysaccharide and appear to form gap junctions with endothelial cells after ischemia-reperfusion. Proc Natl Acad Sci USA 92: 7011-7015, 1995.
61. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6: 131-138, 1986.
62. Krattinger N, Capponi A, Mazzolai L, Aubert JF, Caille D, Nicod P, Waeber G, et al. Connexin40 regulates renin production and blood pressure. Kidney Int 72: 814-822, 2007.
63. Kruger O, Plum A, Kim JS, Winterhager E, Maxeiner S, Hallas G, Kirchhoff S, et al. Defective vascular development in connexin 45-deficient mice. Development 127: 4179-4193, 2000.
64. Kwak BR, Mulhaupt F, Veillard N, Gros DB, Mach F. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 22: 225-230, 2002.
65. Kwak BR, Pepper MS, Gros DB, Meda P. Inhibition of endothelial wound repair by dominant negative connexin inhibitors. Mol Biol Cell 12: 831-845, 2001.
66. Kwak BR, Silacci P, Stergiopulos N, Hayoz D, Meda P. Shear stress and cyclic circumferential stretch, but not pressure, alter connexin43 expression in endothelial cells. Cell Commun Adhes 12: 261-270, 2005.
67. Kwak BR, Veillard N, Pelli G, Mulhaupt F, James RW, Chanson M, Mach F. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation 107: 1033-1039, 2003.
68. Lanfear DE, Jones PG, Marsh S, Cresci S, Spertus JA, McLeod HL. Connexin37 (GJA4) genotype predicts survival after an acute coronary syndrome. Am Heart J 154: 561-566, 2007.
69. Larson DM, Christensen TG, Sagar GD, Beyer EC. TGF-beta1 induces an accumulation of connexin43 in a lysosomal compartment in endothelial cells. Endothelium 8: 255-260, 2001.
70. Larson DM, Wrobleski MJ, Sagar GD, Westphale EM, Beyer EC. Differential regulation of connexin43 and connexin37 in endothelial cells by cell density, growth, and TGF-beta1. Am J Physiol Cell Physiol 272: C405-C415, 1997.
71. Levy JA, Weiss RM, Dirksen ER, Rosen MR. Possible communication between murine macrophages oriented in linear chains in tissue culture. Exp Cell Res 103: 375-385, 1976.
72. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol 143: 1551-1559, 1993.
73. Liao Y, Day KH, Damon DN, Duling BR. Endothelial cell-specific knockout of connexin 43 causes hypotension and bradycardia in mice. Proc Natl Acad Sci USA 98: 9989-9994, 2001.
74. Liao Y, Regan CP, Manabe I, Owens GK, Day KH, Damon DN, Duling BR. Smooth muscle-targeted knockout of connexin43 enhances neointimal formation in response to vascular injury. Arterioscler Thromb Vasc Biol 27: 1037-1042, 2007.
75. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med 8: 1257-1262, 2002.
76. Libby P, Sasiela W. Plaque stabilization: can we turn theory into evidence? Am J Cardiol 98: 26P-33P, 2006.
77. Listi F, Candore G, Balistreri CR, Caruso M, Incalcaterra E, Hoffmann E, Lio D, et al. Connexin37 1019 gene polymorphism in myocardial infarction patients and centenarians. Atherosclerosis 191: 460-461, 2007.
78. Listi F, Candore G, Lio D, Russo M, Colonna-Romano G, Caruso M, Hoffmann E, et al. Association between C1019T polymorphism of connexin37 and acute myocardial infarction: a study in patients from Sicily. Int J Cardiol 102: 269-271, 2005.
79. Little TL, Beyer EC, Duling BR. Connexin 43 and connexin 40 gap junctional proteins are present in arteriolar smooth muscle and endothelium in vivo. Am J Physiol Heart Circ Physiol 268: H729-H739, 1995.
80. Mach F, Schonbeck U, Bonnefoy JY, Pober JS, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96: 396-399, 1997.
81. Makino A, Platoshyn O, Suarez J, Yuan JX, Dillmann WH. Downregulation of connexin40 is associated with coronary endothelial cell dysfunction in streptozotocin-induced diabetic mice. Am J Physiol Cell Physiol 295: C221-C230, 2008.
82. Martin CA, el-Sabban ME, Zhao L, Burakoff R, Homaidan FR. Adhesion and cytosolic dye transfer between macrophages and intestinal epithelial cells. Cell Adhes Commun 5: 83-95, 1998.
83. Massberg S, Schurzinger K, Lorenz M, Konrad I, Schulz C, Plesnila N, Kennerknecht E, et al. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112: 1180-1188, 2005.
84. Mensink A, de Haan LH, Lakemond CM, Koelman CA, Koeman JH. Inhibition of gap junctional intercellular communication between primary human smooth muscle cells by tumor necrosis factor alpha. Carcinogenesis 16: 2063-2067, 1995.
85. Meyer R, Malewicz B, Baumann WJ, Johnson RG. Increased gap junction assembly between cultured cells upon cholesterol supplementation. J Cell Sci 96: 231-238, 1990.
86. Meyer RA, Lampe PD, Malewicz B, Baumann WJ, Johnson RG. Enhanced gap junction formation with LDL and apolipoprotein B. Exp Cell Res 196: 72-81, 1991.
87. Nakamura K, Inai T, Nakamura K, Shibata Y. Distribution of gap junction protein connexin 37 in smooth muscle cells of the rat trachea and pulmonary artery. Arch Histol Cytol 62: 27-37, 1999.
88. Nakamura K, Sasaki T, Cheng XW, Iguchi A, Sato K, Kuzuya M. Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation. Atherosclerosis. Retracted.
89. Newsome LT, Kutcher MA, Royster RL. Coronary artery stents: part I. Evolution of percutaneous coronary intervention. Anesth Analg 107: 552-569, 2008.
90. Oviedo-Orta E, Bermudez-Fajardo A, Karanam S, Benbow U, Newby AC. Comparison of MMP-2 and MMP-9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages. Immunology 124: 42-50, 2008.
91. Oviedo-Orta E, Errington RJ, Evans WH. Gap junction intercellular communication during lymphocyte transendothelial migration. Cell Biol Int 26: 253-263, 2002.
92. Oviedo-Orta E, Hoy T, Evans WH. Intercellular communication in the immune system: differential expression of connexin40 and 43, and perturbation of gap junction channel functions in peripheral blood and tonsil human lymphocyte subpopulations. Immunology 99: 578-590, 2000.
93. Paulsson J, Dadfar E, Held C, Jacobson SH, Lundahl J. Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease. Atherosclerosis 192: 328-334, 2007.
94. Pepper MS, Meda P. Basic fibroblast growth factor increases junctional communication and connexin 43 expression in microvascular endothelial cells. J Cell Physiol 153: 196-205, 1992.
95. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 111: 1805-1812, 2003.
96. Plenz G, Ko YS, Yeh HI, Eschert H, Sindermann JR, Dorszewski A, Hofnagel O, et al. Upregulation of connexin43 gap junctions between neointimal smooth muscle cells. Eur J Cell Biol 83: 521-530, 2004.
97. Polacek D, Bech F, McKinsey JF, Davies PF. Connexin43 gene expression in the rabbit arterial wall: effects of hypercholesterolemia, balloon injury and their combination. J Vasc Res 34: 19-30, 1997.
98. Polacek D, Lal R, Volin MV, Davies PF. Gap junctional communication between vascular cells. Induction of connexin43 messenger RNA in macrophage foam cells of atherosclerotic lesions. Am J Pathol 142: 593-606, 1993.
99. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344: 254-257, 1990.
100. Rignault S, Haefliger JA, Gasser D, Markert M, Nicod P, Liaudet L, Waeber B, et al. Sepsis up-regulates the expression of connexin 40 in rat aortic endothelium. Crit Care Med 33: 1302-1310, 2005.
101. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 83: 1359-1400, 2003.
102. Sampietro T, Bigazzi F, Dal Pino B, Fusaro S, Greco F, Tuoni M, Bionda A. Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: a proinflammatory condition? Circulation 105: 11-14, 2002.
103. Scerri I, Tabary O, Dudez T, Jacquot J, Foglia B, Suter S, Chanson M. Gap junctional communication does not contribute to the interaction between neutrophils and airway epithelial cells. Cell Commun Adhes 13: 1-12, 2006.
104. Schmidt VJ, Wolfle SE, Boettcher M, de Wit C. Gap junctions synchronize vascular tone within the microcirculation. Pharmacol Rep 60: 68-74, 2008.
105. Severs NJ, Rothery S, Dupont E, Coppen SR, Yeh HI, Ko YS, Matsushita T, et al. Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech 52: 301-322, 2001.
106. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 92: 1565-1569, 1995.
107. Sheiban I, Carrieri L, Catuzzo B, Destefanis P, Oliaro E, Moretti C, Trevi GP. Drug-eluting stent: the emerging technique for the prevention of restenosis. Minerva Cardioangiol 50: 443-453, 2002.
108. Sheu JJ, Chang LT, Chiang CH, Sun CK, Chang NK, Youssef AA, Wu CJ, et al. Impact of diabetes on cardiomyocyte apoptosis and connexin43 gap junction integrity: role of pharmacological modulation. Int Heart J 48: 233-245, 2007.
109. Simon AM, Goodenough DA, Li E, Paul DL. Female infertility in mice lacking connexin 37. Nature 385: 525-529, 1997.
110. Simon AM, McWhorter AR. Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol 251: 206-220, 2002.
111. Simon AM, McWhorter AR, Chen H, Jackson CL, Ouellette Y. Decreased intercellular communication and connexin expression in mouse aortic endothelium during lipopolysaccharide-induced inflammation. J Vasc Res 41: 323-333, 2004.
112. Sohl G, Willecke K. Gap junctions and the connexin protein family. Cardiovasc Res 62: 228-232, 2004.
113. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272: 20963-20966, 1997.
114. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 92: 3893-3897, 1995.
115. Suarez S, Ballmer-Hofer K. VEGF transiently disrupts gap junctional communication in endothelial cells. J Cell Sci 114: 1229-1235, 2001.
116. Tacheau C, Fontaine J, Loy J, Mauviel A, Verrecchia F. TGF-beta induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways. J Cell Physiol 217: 759-768, 2008.
117. Tacheau C, Laboureau J, Mauviel A, Verrecchia F. TNF-alpha represses connexin43 expression in HaCat keratinocytes via activation of JNK signaling. J Cell Physiol 216: 438-444, 2008.
118. Theilmeier G, Michiels C, Spaepen E, Vreys I, Collen D, Vermylen J, Hoylaerts MF. Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood 99: 4486-4493, 2002.
119. Theis M, de Wit C, Schlaeger TM, Eckardt D, Kruger O, Doring B, Risau W, et al. Endothelium-specific replacement of the connexin43 coding region by a lacZ reporter gene. Genesis 29: 1-13, 2001.
120. Thuringer D. The vascular endothelial growth factor-induced disruption of gap junctions is relayed by an autocrine communication via ATP release in coronary capillary endothelium. Ann NY Acad Sci 1030: 14-27, 2004.
121. Tsai CH, Yeh HI, Tian TY, Lee YN, Lu CS, Ko YS. Down-regulating effect of nicotine on connexin43 gap junctions in human umbilical vein endothelial cells is attenuated by statins. Eur J Cell Biol 82: 589-595, 2004.
122. van Kempen MJ, Jongsma HJ. Distribution of connexin37, connexin40 and connexin43 in the aorta and coronary artery of several mammals. Histochem Cell Biol 112: 479-486, 1999.
123. van Rijen HV, van Kempen MJ, Postma S, Jongsma HJ. Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells. Cytokine 10: 258-264, 1998.
124. Vaughan CJ, Gotto AM Jr, Basson CT. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol 35: 1-10, 2000.
125. Verheule S, van Kempen MJ, te Welscher PH, Kwak BR, Jongsma HJ. Characterization of gap junction channels in adult rabbit atrial and ventricular myocardium. Circ Res 80: 673-681, 1997.
126. Verma S, Yeh ET. C-reactive protein and atherothrombosis-beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol 285: R1253-R1256; discussion R7-R8, 2003.
127. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 47: C13-C18, 2006.
128. Virmani R, Burke AP, Kolodgie FD, Farb A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol 15: 439-446, 2002.
129. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20: 1262-1275, 2000.
130. Wang L, Chen J, Sun Y, Zhang F, Zhu J, Hu S, Wang DH. Regulation of connexin expression after balloon injury: possible mechanisms for antiproliferative effect of statins. Am J Hypertens 18: 1146-1153, 2005.
131. Wang Q, Zhu X, Xu Q, Ding X, Chen YE, Song Q. Effect of C-reactive protein on gene expression in vascular endothelial cells. Am J Physiol Heart Circ Physiol 288: H1539-H1545, 2005.
132. White HD, Chew DP. Acute myocardial infarction. Lancet 372: 570-584, 2008.
133. Wong CW, Burger F, Pelli G, Mach F, Kwak BR. Dual benefit of reduced Cx43 on atherosclerosis in LDL receptor-deficient mice. Cell Commun Adhes 10: 395-400, 2003.
134. Wong CW, Christen T, Pfenniger A, James RW, Kwak BR. Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? Atherosclerosis 191: 355-361, 2007.
135. Wong CW, Christen T, Roth I, Chadjichristos CE, Derouette JP, Foglia BF, Chanson M, et al. Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 12: 950-954, 2006.
136. Xie HQ, Hu VW. Modulation of gap junctions in senescent endothelial cells. Exp Cell Res 214: 172-176, 1994.
137. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, Sone T, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347: 1916-1923, 2002.
138. Yeh HI, Chang HM, Lu WW, Lee YN, Ko YS, Severs NJ, Tsai CH. Age-related alteration of gap junction distribution and connexin expression in rat aortic endothelium. J Histochem Cytochem 48: 1377-1389, 2000.
139. Yeh HI, Chou Y, Liu HF, Chang SC, Tsai CH. Connexin37 gene polymorphism and coronary artery disease in Taiwan. Int J Cardiol 81: 251-255, 2001.
140. Yeh HI, Lai YJ, Chang HM, Ko YS, Severs NJ, Tsai CH. Multiple connexin expression in regenerating arterial endothelial gap junctions. Arterioscler Thromb Vasc Biol 20: 1753-1762, 2000.
141. Yeh HI, Lee PY, Su CH, Tian TY, Ko YS, Tsai CH. Reduced expression of endothelial connexins 43 and 37 in hypertensive rats is rectified after 7-day carvedilol treatment. Am J Hypertens 19: 129-135, 2006.
142. Yeh HI, Lu CS, Wu YJ, Chen CC, Hong RC, Ko YS, Shiao MS, et al. Reduced expression of endothelial connexin37 and connexin40 in hyperlipidemic mice: recovery of connexin37 after 7-day simvastatin treatment. Arterioscler Thromb Vasc Biol 23: 1391-1397, 2003.
143. Yeh HI, Lu SK, Tian TY, Hong RC, Lee WH, Tsai CH. Comparison of endothelial cells grown on different stent materials. J Biomed Mater Res 76: 835-841, 2006.
144. Yeh HI, Lupu F, Dupont E, Severs NJ. Upregulation of connexin43 gap junctions between smooth muscle cells after balloon catheter injury in the rat carotid artery. Arterioscler Thromb Vasc Biol 17: 3174-3184, 1997.
145. Yeh HI, Rothery S, Dupont E, Coppen SR, Severs NJ. Individual gap junction plaques contain multiple connexins in arterial endothelium. Circ Res 83: 1248-1263, 1998.
146. Zahler S, Hoffmann A, Gloe T, Pohl U. Gap-junctional coupling between neutrophils and endothelial cells: a novel modulator of transendothelial migration. J Leukoc Biol 73: 118-126, 2003.
147. Zhang YW, Morita I, Zhang L, Shao G, Yao XS, Murota S. Screening of anti-hypoxia/reoxygenation agents by an in vitro method. Part 2: Inhibition of tyrosine kinase activation prevented hypoxia/reoxygenation-induced injury in endothelial gap junctional intercellular communication. Planta Med 66: 119-123, 2000.
148. Zhou X, Caligiuri G, Hamsten A, Lefvert AK, Hansson GK. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 21: 108-114, 2001.